Figures & data
Figure 1 Global availability of noninvasive prenatal genetic testing (NIPT).
Notes: Countries where NIPT is currently marketed or in which marketing deals have been signed are presented. The list of countries was generated from Internet searches of press releases, company websites, industry trade reports, and newspapers/popular press articles between January 1, 2012 and April 30, 2014. The list is not exhaustive, as we relied only on publicly available information in English. Only commercial offerings of NIPT for chromosomal aneuploidies using cell-free fetal DNA are included. Numbered countries are as follows: 1) Portugal, 2) Ireland, 3) United Kingdom, 4) Norway, 5) Sweden, 6) Finland, 7) Denmark, 8) the Netherlands, 9) Luxembourg, 10) Belgium, 11) Germany, 12) Switzerland, 13) Liechtenstein, 14) Italy, 15) Austria, 16) Czech Republic, 17) Slovakia, 18) Hungary, 19) Slovenia, 20) Croatia, 21) Romania, 22) Bulgaria, 23) Albania, 24) Greece, 25) Tunisia, 26) Cyprus, 27) Lebanon, 28) Israel, 29) Jordan, 30) Kuwait, 31) Bahrain, 32) Qatar, and 33) United Arab Emirates.
